• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病病理学:不同类型痴呆患者队列中慢性血管危险因素与血脑屏障功能障碍之间的通路

Alzheimer's disease pathology: pathways between chronic vascular risk factors and blood-brain barrier dysfunction in a cohort of patients with different types of dementia.

作者信息

Gan Jinghuan, Yang Xia, Zhang Guili, Li Xudong, Liu Shuai, Zhang Wei, Ji Yong

机构信息

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Department of Cognitive Disorder, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

出版信息

Front Aging Neurosci. 2023 May 4;15:1088140. doi: 10.3389/fnagi.2023.1088140. eCollection 2023.

DOI:10.3389/fnagi.2023.1088140
PMID:37213537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10194826/
Abstract

BACKGROUND

Blood brain barrier (BBB) breakdown is considered a potential mechanism of dementia. The Alzheimer's disease (AD) biomarkers and vascular factors are also associated with BBB permeability.

OBJECTIVE

In the present study, the combination effects of neuropathological biomarkers of AD and chronic vascular risk factors for BBB were investigated.

METHODS

The cerebrospinal fluid (CSF)/serum albumin ratio (Qalb), an indicator of BBB permeability, was measured in a total of 95 hospitalized dementia patients. The demographics, clinical information, and laboratory tests were collected from the inpatient records. The CSF neuropathological biomarkers of AD and apolipoprotein E (APOE) genotype were also collected. The mediation analysis model was used to calculate the associations among neuropathological biomarkers of AD (mediator), the Qalb, and chronic vascular risk factors.

RESULTS

Three types of dementia, AD ( = 52), Lewy body dementia (LBD, = 19), and frontotemporal lobar degeneration ( = 24), were included with a mean Qalb of 7.18 (± 4.36). The Qalb was significantly higher in dementia patients with type 2 diabetes mellitus (T2DM, = 0.004) but did not differ based on the presence of APOE ε4 allele, CMBs, or amyloid/tau/neurodegeneration (ATN) framework. The Qalb was negatively associated with the levels of Aβ1-42 (B = -20.775, = 0.009) and Aβ1-40 (B = -305.417, = 0.005) and positively associated with the presence of T2DM (B = 3.382, < 0.001) and the levels of glycosylated hemoglobin (GHb, B = 1.163, < 0.001) and fasting blood glucose (FBG, B = 1.443, < 0.001). GHb is a direct chronic vascular risk factor for higher Qalb (total effect B = 1.135, 95% CI: 0.611-1.659, < 0.001). Ratios of Aβ1-42/Aβ1-40 or t-tau/Aβ1-42 were mediators of the association between the Qalb and GHb; the direct effect of GHb on the Qalb was 1.178 (95% CI: 0.662-1.694, < 0.001).

CONCLUSION

Glucose exposure can directly or indirectly affect BBB integrity through Aβ and tau, indicating glucose affects BBB breakdown and glucose stability plays an important role in dementia protection and management.

摘要

背景

血脑屏障(BBB)破坏被认为是痴呆症的一种潜在机制。阿尔茨海默病(AD)生物标志物和血管因素也与BBB通透性相关。

目的

在本研究中,调查了AD神经病理学标志物与BBB慢性血管危险因素的联合作用。

方法

对总共95名住院痴呆患者测量了脑脊液(CSF)/血清白蛋白比率(Qalb),这是BBB通透性的一个指标。从住院记录中收集人口统计学、临床信息和实验室检查结果。还收集了AD的CSF神经病理学标志物和载脂蛋白E(APOE)基因型。使用中介分析模型来计算AD神经病理学标志物(中介变量)、Qalb和慢性血管危险因素之间的关联。

结果

纳入了三种类型的痴呆症,即AD(n = 52)、路易体痴呆(LBD,n = 19)和额颞叶变性(n = 24),平均Qalb为7.18(±4.36)。2型糖尿病(T2DM)痴呆患者的Qalb显著更高(P = 0.004),但基于APOE ε4等位基因、脑微出血(CMBs)或淀粉样蛋白/ tau /神经变性(ATN)框架的存在情况并无差异。Qalb与Aβ1 - 42水平呈负相关(B = -20.775,P = 0.009)和Aβ1 - 40水平呈负相关(B = -305.417,P = 0.005),与T2DM的存在呈正相关(B = 3.382,P < 0.001)以及与糖化血红蛋白(GHb,B = 1.163,P < 0.001)和空腹血糖(FBG,B = 1.443,P < 0.001)水平呈正相关。GHb是导致Qalb升高的直接慢性血管危险因素(总效应B = 1.135,95%CI:0.611 - 1.659,P < 0.001)。Aβ1 - 42/Aβ1 - 40或t - tau/Aβ1 - 42比率是Qalb与GHb之间关联的中介变量;GHb对Qalb的直接效应为1.178(95%CI:0.662 - 1.694,P < 0.001)。

结论

葡萄糖暴露可通过Aβ和tau直接或间接影响BBB完整性,表明葡萄糖影响BBB破坏,且葡萄糖稳定性在痴呆症的预防和管理中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb96/10194826/8d643c3cae53/fnagi-15-1088140-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb96/10194826/09f458e8ba99/fnagi-15-1088140-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb96/10194826/4e551f9b64fe/fnagi-15-1088140-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb96/10194826/f7ba50dc4526/fnagi-15-1088140-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb96/10194826/8d643c3cae53/fnagi-15-1088140-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb96/10194826/09f458e8ba99/fnagi-15-1088140-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb96/10194826/4e551f9b64fe/fnagi-15-1088140-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb96/10194826/f7ba50dc4526/fnagi-15-1088140-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb96/10194826/8d643c3cae53/fnagi-15-1088140-g0004.jpg

相似文献

1
Alzheimer's disease pathology: pathways between chronic vascular risk factors and blood-brain barrier dysfunction in a cohort of patients with different types of dementia.阿尔茨海默病病理学:不同类型痴呆患者队列中慢性血管危险因素与血脑屏障功能障碍之间的通路
Front Aging Neurosci. 2023 May 4;15:1088140. doi: 10.3389/fnagi.2023.1088140. eCollection 2023.
2
Effect of Vascular Risk Factors on Blood-Brain Barrier and Cerebrospinal Fluid Biomarkers Along the Alzheimer's Disease Continuum: A Retrospective Observational Study.血管危险因素对阿尔茨海默病连续体中血脑屏障和脑脊液生物标志物的影响:一项回顾性观察研究。
J Alzheimers Dis. 2024;97(2):599-607. doi: 10.3233/JAD-230792.
3
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype.血脑屏障通透性增加与痴呆症和糖尿病有关,但与淀粉样蛋白病理或载脂蛋白E基因型无关。
Neurobiol Aging. 2017 Mar;51:104-112. doi: 10.1016/j.neurobiolaging.2016.11.017. Epub 2016 Dec 5.
4
Investigating the association of ApoE genotypes with blood-brain barrier dysfunction measured by cerebrospinal fluid-serum albumin ratio in a cohort of patients with different types of dementia.在一组不同类型痴呆患者中,研究载脂蛋白E(ApoE)基因分型与通过脑脊液-血清白蛋白比率测量的血脑屏障功能障碍之间的关联。
PLoS One. 2013 Dec 27;8(12):e84405. doi: 10.1371/journal.pone.0084405. eCollection 2013.
5
Blood-Brain Barrier Dysfunction and Aβ42/40 Ratio Dose-Dependent Modulation with the ApoE Genotype within the ATN Framework.在 ATN 框架内,载脂蛋白 E 基因型与血脑屏障功能障碍和 Aβ42/40 比值剂量相关性调节。
Int J Mol Sci. 2023 Jul 29;24(15):12151. doi: 10.3390/ijms241512151.
6
Correlation of blood-brain barrier leakage with cerebral small vessel disease including cerebral microbleeds in Alzheimer's disease.血脑屏障渗漏与包括阿尔茨海默病脑微出血在内的脑小血管疾病的相关性。
Front Neurol. 2023 Feb 16;14:1077860. doi: 10.3389/fneur.2023.1077860. eCollection 2023.
7
Association between elevated blood-brain barrier permeability and the risk of progressive cognitive decline: A longitudinal study.血脑屏障通透性升高与认知进行性下降风险的关联:一项纵向研究。
Arch Gerontol Geriatr. 2024 Sep;124:105441. doi: 10.1016/j.archger.2024.105441. Epub 2024 Apr 20.
8
Blood-brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer's disease.血脑屏障通透性与阿尔茨海默病的不同神经炎症特征有关。
Eur J Neurol. 2024 Jan;31(1):e16095. doi: 10.1111/ene.16095. Epub 2023 Oct 12.
9
Cerebrospinal fluid/serum albumin ratio in patients with Lewy body disease: a systematic review and meta-analysis.路易体病患者脑脊液/血清白蛋白比值:一项系统评价和荟萃分析。
Front Aging Neurosci. 2024 May 2;16:1390036. doi: 10.3389/fnagi.2024.1390036. eCollection 2024.
10
High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.路易体痴呆患者脑脊液中载脂蛋白 E 水平升高与痴呆有关。
Alzheimers Dement. 2014 Sep;10(5):530-540.e1. doi: 10.1016/j.jalz.2013.03.010. Epub 2013 Aug 24.

引用本文的文献

1
The role of insulin resistance and APOE genotype on blood-brain barrier integrity in Alzheimer's disease.胰岛素抵抗和APOE基因型在阿尔茨海默病血脑屏障完整性中的作用。
Alzheimers Dement. 2025 Feb;21(2):e14556. doi: 10.1002/alz.14556.
2
Blood-brain barrier breakdown in dementia with Lewy bodies.路易体痴呆症中的血脑屏障破坏。
Fluids Barriers CNS. 2024 Sep 17;21(1):73. doi: 10.1186/s12987-024-00575-z.
3
Associations between regional blood-brain barrier permeability, aging, and Alzheimer's disease biomarkers in cognitively normal older adults.

本文引用的文献

1
Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function.外周型载脂蛋白 E4 通过损害脑血管功能增强阿尔茨海默病病理并损害认知。
Nat Neurosci. 2022 Aug;25(8):1020-1033. doi: 10.1038/s41593-022-01127-0. Epub 2022 Aug 1.
2
Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis.路易体谱系疾病中血脑屏障破坏和神经退行性变的生物流体标志物:系统评价和荟萃分析。
Parkinsonism Relat Disord. 2022 Aug;101:119-128. doi: 10.1016/j.parkreldis.2022.06.004. Epub 2022 Jun 20.
3
Elevated Plasma Orexin-A Levels in Prodromal Dementia with Lewy Bodies.
认知正常的老年人中区域血脑屏障通透性、衰老与阿尔茨海默病生物标志物的相关性。
PLoS One. 2024 Jun 5;19(6):e0299764. doi: 10.1371/journal.pone.0299764. eCollection 2024.
4
Cerebrospinal fluid/serum albumin ratio in patients with Lewy body disease: a systematic review and meta-analysis.路易体病患者脑脊液/血清白蛋白比值:一项系统评价和荟萃分析。
Front Aging Neurosci. 2024 May 2;16:1390036. doi: 10.3389/fnagi.2024.1390036. eCollection 2024.
5
Association between cerebrospinal fluid pressure and cognition in patients with Alzheimer's disease and Lewy body dementia.阿尔茨海默病和路易体痴呆患者脑脊液压力与认知的关系。
BMC Neurol. 2024 Jan 19;24(1):35. doi: 10.1186/s12883-023-03502-1.
6
Mechanistic Intimate Insights into the Role of Hydrogen Sulfide in Alzheimer's Disease: A Recent Systematic Review.硫化氢在阿尔茨海默病中作用的机制深入见解:最近的系统评价。
Int J Mol Sci. 2023 Oct 23;24(20):15481. doi: 10.3390/ijms242015481.
路易体痴呆前驱期血浆食欲素-A 水平升高。
J Alzheimers Dis. 2022 Jun 14;88(3):1037-1048. doi: 10.3233/JAD-220082.
4
accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer's mice via cyclophilin A independently of amyloid-β.通过亲环素 A 加速老年阿尔茨海默病小鼠晚期血管和神经退行性疾病,与淀粉样蛋白-β无关。
Nat Aging. 2021 Jun;1(6):506-520. doi: 10.1038/s43587-021-00073-z. Epub 2021 Jun 14.
5
Endothelial Progenitor Cells and Vascular Alterations in Alzheimer's Disease.阿尔茨海默病中的内皮祖细胞与血管改变
Front Aging Neurosci. 2022 Jan 26;13:811210. doi: 10.3389/fnagi.2021.811210. eCollection 2021.
6
Characteristics of Cortical Atrophy and White Matter Lesions Between Dementia With Lewy Bodies and Alzheimer's Disease: A Case-Control Study.路易体痴呆与阿尔茨海默病之间皮质萎缩和白质病变的特征:一项病例对照研究。
Front Neurol. 2022 Jan 11;12:779344. doi: 10.3389/fneur.2021.779344. eCollection 2021.
7
APOE4 derived from astrocytes leads to blood-brain barrier impairment.源自星形胶质细胞的载脂蛋白E4会导致血脑屏障受损。
Brain. 2022 Oct 21;145(10):3582-3593. doi: 10.1093/brain/awab478.
8
The influence of cerebrovascular disease in dementia with Lewy bodies and Parkinson's disease dementia.路易体痴呆和帕金森病痴呆中脑血管病的影响。
Eur J Neurol. 2022 Apr;29(4):1254-1265. doi: 10.1111/ene.15211. Epub 2022 Jan 20.
9
Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.阿尔茨海默病中血脑屏障功能障碍:来自人体研究的证据。
Neuropathol Appl Neurobiol. 2022 Apr;48(3):e12782. doi: 10.1111/nan.12782. Epub 2022 Feb 2.
10
Valsartan alleviates the blood-brain barrier dysfunction in db/db diabetic mice.缬沙坦可减轻 db/db 糖尿病小鼠的血脑屏障功能障碍。
Bioengineered. 2021 Dec;12(1):9070-9080. doi: 10.1080/21655979.2021.1981799.